ACTIVE

Service d'Oncologie Radiothérapie Médecine Nucléaire

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result0,4 €+109,0 %over 1 year
Gross margin13,6 k €+4,0 %over 1 year
Equity40,6 k €+7,1 %over 1 year

Identity

Source · BCE/KBO

Service d'Oncologie Radiothérapie Médecine Nucléaire is a Cooperative society incorporated in 2007. Its main activity is: Other human health activities. Its registered office is in Namur.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0888.714.988
Incorporation
12/04/2007
Legal form
Cooperative society
Registered office
Chaussée de Dinant(WP) 894
5100 Namur · WallonieSee on map
Contributed capital
37 211,08 €
Latest accounts
31/12/2025
Signals
ProfitablePositive cashflowPositive EBITDA

Financials

Source · NBB, 18 filings

Trend over 18 financial years

20252024202320222021
Income statement
Gross margin13,6 k €13 k €14,6 k €16,7 k €15,9 k €
EBITDA12,3 k €11,8 k €13,3 k €15,6 k €14,8 k €
Operating result10,7 k €10,3 k €13,3 k €15,6 k €14,8 k €
Net result0,4 €-4,8 €3,4 €-7 €11,1 €
Balance sheet
Equity40,6 k €38 k €37,5 k €33,9 k €32,1 k €
Total assets3,3 M €3 M €1,6 M €1,1 M €1,4 M €
Cash1,3 M €653,4 k €70,3 k €54,5 k €73,2 k €
Debts3,3 M €2,9 M €1,6 M €1,1 M €1,4 M €
Other
Workforce–––––

Valuation

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

3 active · 6 ended

Active mandates

DirectorMandates in this companyPeriodOther mandatescurrentendedstruck offbankruptcies
BEVERGAM0464.913.179Represented by Bernard WILLEMART
Managing director31/05/2014 → 25/05/2029
DR GABRIËL0648.702.841Represented by Stéphanie GABRIËL
Director16/01/2024 → 25/05/2029
DR VINCENT VANHAUDENARDE ONCOLOGIE0501.783.869Represented by Vincent VANHAUDENARDE
Director01/11/2019 → 25/05/2029

Ended mandates

DirectorMandates in this companyPeriodOther mandatescurrentendedstruck offbankruptcies
Peter VUYLSETKE
Director24/05/2019 → 31/10/2019
RADIONC REMOUCHAMPS0822.162.201Represented by Vincent REMOUCHAMPS
Director24/05/2019 → 24/05/2024
Peter VUYLSTEKE
Director01/10/2014 → 31/05/2019

Other companies at this address

Chaussée de Dinant(WP) 894 5100 Namur
CompanyCBE no.
BEVERGAM● Active
0464.913.179
FINAWEP● Active
0769.833.372

Full financial information

Source · NBB
202520242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date28/05/202603/06/202512/06/202401/06/202314/06/202231/05/2021
General meeting12/05/202616/05/202531/05/202426/05/202325/05/202228/05/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 18 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202512/05/202628/05/2026FrenchPDF
Abridged model31/12/202416/05/202503/06/2025FrenchPDF
Abridged model31/12/202331/05/202412/06/2024FrenchPDF
Abridged model31/12/202226/05/202301/06/2023FrenchPDF
Abridged model31/12/202125/05/202214/06/2022FrenchPDF
Abridged model31/12/202028/05/202131/05/2021FrenchPDF
Abridged model31/12/201929/05/202016/06/2020FrenchPDF
Abridged model31/12/201824/05/201911/06/2019FrenchPDF
Abridged model31/12/201725/05/201801/06/2018FrenchPDF
Abridged model31/12/201612/05/201714/06/2017FrenchPDF
Abridged model31/12/201527/05/201609/06/2016FrenchPDF
Abridged model31/12/201422/05/201501/07/2015FrenchPDF
Abridged model31/12/201330/05/201404/06/2014FrenchPDF
Abridged model31/12/201231/05/201320/06/2013FrenchPDF
Abridged model30/09/201116/03/201221/03/2012FrenchPDF
Abridged model30/09/201018/03/201131/03/2011FrenchPDF
Abridged model30/09/200919/03/201026/03/2010FrenchPDF
Abridged model30/09/200820/03/200931/03/2009FrenchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

3 active · 6 ended

Active mandates

DirectorMandates in this companyPeriodOther mandatescurrentendedstruck offbankruptcies
BEVERGAM0464.913.179Represented by Bernard WILLEMART
Managing director31/05/2014 → 25/05/2029
DR GABRIËL0648.702.841Represented by Stéphanie GABRIËL
Director16/01/2024 → 25/05/2029
DR VINCENT VANHAUDENARDE ONCOLOGIE0501.783.869Represented by Vincent VANHAUDENARDE
Director01/11/2019 → 25/05/2029

Ended mandates

DirectorMandates in this companyPeriodOther mandatescurrentendedstruck offbankruptcies
Peter VUYLSETKE
Director24/05/2019 → 31/10/2019
RADIONC REMOUCHAMPS0822.162.201Represented by Vincent REMOUCHAMPS
Director24/05/2019 → 24/05/2024
Peter VUYLSTEKE
Director01/10/2014 → 31/05/2019

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates01/02/2024
    STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …) - MODIFICATION FORME JURIDIQUE - DEMISSIONS, NOMINATIONS
    PDF
  • Mandates08/08/2019
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates24/07/2015
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates03/09/2012
    OBJET - DEMISSIONS, NOMINATIONS - ASSEMBLEE GENERALE - ANNEE COMPTABLE - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …) - MODIFICATION FORME JURIDIQUE
    PDF
  • Other23/04/2007
    RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts
Year
Identity
Incorporation
Name
Registered office
Annual accounts
Filings18 filings
Mandates
BEVERGAM
DR VINCENT VANHAUDENARDE ONCOLOGIE
DR GABRIËL
RADIONC REMOUCHAMPS
Peter VUYLSETKE
Peter VUYLSTEKE
ONCONAM
DAISNE-COPINE
20072008200920102011201220132014201520162017201820192020202120222023202420252026202720282029
SORMN
Chaussée de Dinant(WP) 894, 5100 Jambes (Namur)
Managing director
Director
Director
Director
Director
Director
Director
CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE
Registered addressPeriodSource
Chaussée de Dinant(WP) 894, 5100 Jambes (Namur)Current
accounts 2021 → 2025
Accounts 2025 · 2026-00127110

Company names

Source · NBB annual accounts, CBE
NamePeriodSource
Service d'Oncologie Radiothérapie Médecine NucléaireCurrent
CBE
SORMN
accounts 2021 → 2025
Accounts 2025 · 2026-00127110

Events

  1. 2025
    Annual accounts 20250,4 €↑
  2. 2024
    Annual accounts 2024-4,8 €↓
  3. 2023
    Annual accounts 20233,4 €↑
  4. 2022
    Annual accounts 2022-7 €↓
  5. 2021
    Annual accounts 202111,1 €↑
  6. 2020
    Annual accounts 2020-203,6 €↓
  7. 2019
    Annual accounts 20196,1 €↓
  8. 2018
    Annual accounts 2018196,6 €↑
  9. 2017
    Annual accounts 20172,7 €↓
  10. 2016
    Annual accounts 201616,2 €↓
  11. 2015
    Annual accounts 20151,1 M €↓
  12. 2014
    Annual accounts 20141,2 M €↑
  13. 2013
    Annual accounts 20131,1 M €↓
  14. 2012
    Annual accounts 20121,4 M €↑
  15. 2011
    Annual accounts 201130,6 k €↑
  16. 2010
    Annual accounts 201027,9 k €↓
  17. 2009
    Annual accounts 200936,2 k €↓
  18. 2008
    Annual accounts 2008723,5 k €
  19. 12/04/2007
    IncorporationCooperative society